Ocugen filed a registration statement with the Securities and Exchange Commission on August 13, 2025.

The entities involved

• Ocugen →

  biopharmaceutical company

  • Ocugen executed an agreement with Global Alliance for Regenerative Medicine to manage patient care.Wed 14:20
• Securities and Exchange Commission →

  government agency of the Philippines

  • Director of Snowflake Inc. sold company shares in a large transaction and filed required 13F reports with the SEC.05:07
  • Tenable Holdings, Inc. received a positive rating and a $44.00 price target from financial firms, alongside a stock sale disclosure to the SEC.04:58

Related events

• Ovintiv submitted filings to the Securities and Exchange Commission.Jun 24
• 60 Degrees Pharmaceuticals, Inc. filed a registration statement with the Securities and Exchange Commission on July 17, 2025.Jun 8
• The Securities and Exchange Commission approved registration statements for Lycia Therapeutics, Inc. on October 1, 2026.Oct 23
• O’Reilly Automotive, Inc. traded on the Nasdaq exchange and filed required documents with the SEC on July 24, 2026.Jul 24
• EVgo filed required documents with the SEC and its board reviewed an unsolicited acquisition proposal.Mon 22:54